Timeline for NSAID-Induced Erosive Gastritis
Erosive gastritis from NSAIDs develops rapidly—endoscopic erosions appear in approximately 60% of patients within the first 1-2 weeks of therapy, though the risk persists throughout the entire duration of NSAID use. 1, 2, 3
Acute Phase (First 1-4 Weeks)
Gastric erosions emerge quickly and almost uniformly across patients, with acute cellular damage occurring within days of initiating therapy. 4
By 1 week of NSAID use, subepithelial hemorrhages and erosions are already visible on endoscopy in the majority of chronic users. 2
At 12 weeks, even low-dose enteric-coated aspirin (81 mg/day) produces endoscopic ulcers and erosions in 7.3% of osteoarthritis patients. 1
Among patients taking aspirin for more than 3 months (100-325 mg/day), 48% of asymptomatic individuals develop endoscopic ulcers and erosions. 1
Approximately 60% of patients receiving long-term NSAID therapy develop gastric erosions, with 10-30% progressing to frank gastric ulcers. 2, 3
Chronic Risk Profile
Although the highest risk occurs immediately after initiation, there remains a continued and persistent risk over time such that patients are always at risk while taking NSAIDs. 1
The development of serious complications (bleeding, perforation, obstruction) requires progression from erosions to ulcers, which typically occurs over weeks to months. 2
Approximately 0.75% of patients taking NSAIDs for 6 months develop clinically significant complications from ulcers or erosions. 2
Critical Clinical Distinctions
Endoscopic findings do not correlate well with symptoms—many patients with significant erosive damage remain asymptomatic, while others experience dyspepsia without visible lesions. 5, 2
NSAIDs do not cause diffuse histologic gastritis (inflammatory cell infiltration); any such gastritis is due to H. pylori infection and remains unchanged by NSAID ingestion. 6, 2
The acute gastric injury from NSAIDs results from both topical cellular damage and impaired mucosal healing, not from inflammatory changes. 4
Risk Amplification Factors
Advancing age increases GI risk by approximately 4% per year, with patients over 70 years at particularly high risk. 1, 7
History of previous peptic ulcer increases the likelihood of a GI event with an odds ratio as high as 13.5. 1
Concurrent use of aspirin plus NSAIDs increases the relative risk of GI bleeding to more than 10 times that of either agent alone. 1
Concomitant corticosteroids, anticoagulants, or multiple NSAIDs further elevate risk substantially. 1, 7
Common Pitfalls
Do not assume that absence of symptoms means absence of erosive damage—erosions develop silently in the majority of patients. 2
Do not rely on enteric coating or buffering to prevent gastric toxicity—these formulations do not attenuate GI complications. 1
Do not underestimate the risk with "safer" NSAIDs like ibuprofen—while they may have relatively lower GI toxicity, erosions still develop in the majority of chronic users. 1, 2